PAVmed (PAVM) PT Raised to $8 at Maxim Group, Following Business Update
Tweet
Share
E-mailGet Alerts PAVM Hot Sheet
Price: $4.74 +12.59%
Rating Summary:
5 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
5 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Maxim Group analyst Anthony Vendetti raised the price target on PAVmed (NASDAQ: PAVM) to $8.00 (from $5.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results
- Fast Retailing Co Ltd. (9983:JP) (FRCOY) PT Raised to JPY77,000 at Nomura/Instinet
- Greens (6547:JP) PT Raised to JPY3,800 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Maxim GroupSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
